You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer

 

Online download statistics by month:

Online download statistics by month: February 2022 to July 2025

AbstractFullPdf
Feb 2022368388102
Mar 2022249254165
Apr 202216116881
May 202212613348
Jun 202213213439
Jul 202213914154
Aug 202216216438
Sep 202215115156
Oct 202214114639
Nov 2022939319
Dec 2022666717
Jan 2023545620
Feb 2023767628
Mar 2023272839
Apr 2023282824
May 2023272817
Jun 2023383821
Jul 2023292914
Aug 2023404016
Sep 2023262717
Oct 2023272921
Nov 2023404020
Dec 2023404127
Jan 2024292911
Feb 2024333327
Mar 2024373757
Apr 2024434337
May 2024343423
Jun 2024424124
Jul 2024444521
Aug 2024333417
Sep 2024303013
Oct 2024313118
Nov 2024353623
Dec 2024343524
Jan 2025262623
Feb 2025272716
Mar 2025393918
Apr 2025676822
May 2025474827
Jun 2025202019
Jul 2025110
Total289229561342